Home at last

Last year, one of my Montaigne posts included his description of his library, which is one of the few things in life I’m envious of.

But now the New York Observer tells me it can all be ours — on Central Park West, no less — for a mere $7.5 million!

Seriously, go over to the architect’s site and check out the pix of this gorgeous duplex. Then send me money so I can buy the place. I promise I’ll let you come over.

(But I bet the co-op board has a “No dogs” policy. Grr.)

Last day!

The production schedule read, “Final Materials to Printer – July 2,” and I’m gonna get those final materials to the printer by July 2! Just a couple hundred words more about Pfizer and a brief writeup about Abbott Laboratories, and this year’s Top 20 Pharma / Top 10 Biopharma ish will be finished!

So don’t expect any more posts today.

In other news, it looks like the constant dreariness and rainfall of June has had at least one positive effect: the deer have had enough to eat in the woods and have (mostly) left my tigerlilies alone!

What It Is: 6/29/09

What I’m reading: Plutarch’s life of Aemilius Paulus, and a little of The Hunter, a Richard Stark (Donald Westlake) book. But I’m in the home-stretch for my Top Companies ish, so I’ve just been reading a lot of SEC filings, analyst reports and various pharma-bloggers.

What I’m listening to: A whole ton of Michael Jackson music.

What I’m watching: A whole ton of Michael Jackson videos. And the Yankees beating up the Mets.

What I’m drinking: Blue Point Blueberry Ale.

What Rufus is up to: Going on his first greyhound hike in about 8 weeks and having a great time catching up with his pals.

Where I’m going: On a weeklong vacation (to nowhere) once this issue is done.

What I’m happy about: The Top Companies issue is just about done. It’s gonna be a hard couple of days to finish it, but I can visualize the end of it.

What I’m sad about: That Dad’s gout has stuck around, making his life pretty miserable.

What I’m worried about: Getting in trouble because I failed to mail back my jury duty notice. See, I misread the form and thought I was only supposed to mail it in if I was trying to get a deferral. Oops. On the upside, my juror number is above the cut-off point, so I won’t have to go serve on Tuesday.

What I’m pondering: Whether Ron Rosenbaum knows anyone under the age of 40.

Worse than Ezra

Ahoy, ahoy, dear readers! I’m way too busy reading pharmaco financials and analyst reports to spend much time blogging. Updates will be pretty light until July 4thish. (Of course there’ll be an Unrequired Reading this Friday! Don’t be silly!)

Just so you get your fix, the 0-fer of the week is . . . Ezra Pound!

Now I gotta get back to work. Later!